0 0
Read Time:1 Minute, 46 Second

A recent study published in JCO Oncology Advances suggests that short-course vaginal cuff brachytherapy (VCB) is a viable alternative to standard regimens for short-term quality of life in patients with early-stage endometrial cancer. The findings indicate that this approach could improve resource utilization and expand access to care without compromising treatment outcomes.

The study, led by Dr. Gita Suneja from the Huntsman Cancer Institute at the University of Utah, involved 108 patients diagnosed with endometrioid adenocarcinoma, serous sarcoma, clear cell sarcoma, or carcinosarcoma (stage I or II) following hysterectomy. Researchers compared the effects of short-course VCB (11 Gy × two fractions at the surface) against standard regimens (7 Gy × three fractions at 0.5 cm depth; 6 Gy × five fractions at the vaginal surface; or 5 to 5.5 Gy × four fractions at 0.5 cm depth).

The study utilized the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core Module to assess Global Health Status. Results showed that two fractions of short-course VCB were noninferior to standard care at both one and 12 months post-treatment. Additionally, patient-reported symptoms related to vaginal/sexual health, urologic function, and gastrointestinal issues did not significantly differ between treatment arms.

Short-term adverse events were reported in 37% of patients receiving the experimental regimen compared to 57% in the control group. At a median follow-up of 28 months, both groups demonstrated a 96% vaginal control rate, further supporting the effectiveness of the short-course approach.

“This approach, while maintaining short-term local control, holds promise in enhancing resource utilization, expanding access to care, and improving the overall treatment experience for individuals with endometrial cancer necessitating adjuvant VCB,” the study authors noted.

However, it is important to acknowledge that several authors of the study disclosed ties to the pharmaceutical industry, which may influence interpretations of the results. Further long-term studies are necessary to fully understand the implications of this treatment approach.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should consult their healthcare providers for personalized treatment recommendations.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %